Research ArticleClinical Investigations
Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients
Wolfgang P. Fendler, Hanna Lechner, Andrei Todica, Karolin J. Paprottka, Philipp M. Paprottka, Tobias F. Jakobs, Marlies Michl, Peter Bartenstein, Sebastian Lehner and Alexander R. Haug
Journal of Nuclear Medicine April 2016, 57 (4) 517-523; DOI: https://doi.org/10.2967/jnumed.115.165050
Wolfgang P. Fendler
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Hanna Lechner
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Andrei Todica
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Karolin J. Paprottka
2Department of Clinical Radiology, Ludwig-Maximilians-University of Munich, Munich, Germany
Philipp M. Paprottka
2Department of Clinical Radiology, Ludwig-Maximilians-University of Munich, Munich, Germany
Tobias F. Jakobs
3Department of Diagnostic and Interventional Radiology, Hospital Barmherzige Brueder, Munich, Germany
Marlies Michl
4Department of Hematology and Oncology, Ludwig-Maximilians-University of Munich, Munich, Germany
Peter Bartenstein
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
5Comprehensive Cancer Center Munich (CCCM), Ludwig-Maximilians-University of Munich, Munich, Germany; and
Sebastian Lehner
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Alexander R. Haug
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
6Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 4
April 1, 2016
Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients
Wolfgang P. Fendler, Hanna Lechner, Andrei Todica, Karolin J. Paprottka, Philipp M. Paprottka, Tobias F. Jakobs, Marlies Michl, Peter Bartenstein, Sebastian Lehner, Alexander R. Haug
Journal of Nuclear Medicine Apr 2016, 57 (4) 517-523; DOI: 10.2967/jnumed.115.165050
Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients
Wolfgang P. Fendler, Hanna Lechner, Andrei Todica, Karolin J. Paprottka, Philipp M. Paprottka, Tobias F. Jakobs, Marlies Michl, Peter Bartenstein, Sebastian Lehner, Alexander R. Haug
Journal of Nuclear Medicine Apr 2016, 57 (4) 517-523; DOI: 10.2967/jnumed.115.165050
Jump to section
Related Articles
Cited By...
- Reshaping the Landscape of Locoregional Treatments for Breast Cancer Liver Metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases survival in BALB/c mice inoculated with 4T1 triple negative breast cancer cells in the liver
- A Novel Injectable Hydrogel Matrix Loaded With 90Y Microspheres for the Treatment of Solid Tumors
- Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
- Liver-dominant Breast Cancer Metastasis: A Comparative Outcomes Study of Chemoembolization Versus Radioembolization
- 18F-FDG PET/CT in Local Ablative Therapies: A Systematic Review
- 68Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate Cancer